GERN Insider Trading
Insider Ownership Percentage: 3.00%
Insider Buying (Last 12 Months): $46,150.00
Insider Selling (Last 12 Months): $6,808,003.88
Geron Share Price & Price History
Current Price: $1.64
Price Change: ▼ Price Decrease of -0.03 (-1.80%)
As of 03/14/2025 05:00 PM ET
Geron Insider Trading History
Geron Institutional Trading History
Data available starting January 2016
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Read More on Geron
Volume
8,619,016 shs
Average Volume
11,363,564 shs
Market Capitalization
$1.04 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.53
Who are the company insiders with the largest holdings of Geron?
Geron's top insider shareholders include:
- John A Scarlett (CEO)
- Scott Alan Samuels (EVP)
- Elizabeth G O'farrell (Director)
- Andrew J Grethlein (COO)
- Faye Feller (EVP)
- Susan Molineaux (Director)
- V Bryan Lawlis (Director)
Learn More about top insider investors at Geron.
Who are the major institutional investors of Geron?
Geron's top institutional investors include:
- Vanguard Group Inc. — 5.55%
- RA Capital Management L.P. — 4.96%
- Janus Henderson Group PLC — 4.48%
- Adage Capital Partners GP L.L.C. — 3.61%
- Wellington Management Group LLP — 2.23%
- Geode Capital Management LLC — 2.17%
Learn More about top institutional investors of Geron stock.
Which major investors are selling Geron stock?
Within the last quarter, GERN stock was sold by these institutional investors:
- Darwin Global Management Ltd.
- Jefferies Financial Group Inc.
- Jefferies Financial Group Inc.
- Adage Capital Partners GP L.L.C.
- Deep Track Capital LP
- Price T Rowe Associates Inc. MD
- RA Capital Management L.P.
- Silverarc Capital Management LLC
In the previous year, company insiders that have sold Geron company stock include:
- John A Scarlett (CEO)
- Scott Alan Samuels (EVP)
- Elizabeth G O'farrell (Director)
Learn More investors selling Geron stock.
Which major investors are buying Geron stock?
During the previous quarter, GERN stock was acquired by institutional investors including:
- Vestal Point Capital LP
- Braidwell LP
- Boxer Capital Management LLC
- Woodline Partners LP
- Janus Henderson Group PLC
- Segall Bryant & Hamill LLC
- Millennium Management LLC
- Tri Locum Partners LP
In the previous year, these company insiders have bought Geron stock:
- John A Scarlett (CEO)
- Scott Alan Samuels (EVP)
- Elizabeth G O'farrell (Director)
Learn More investors buying Geron stock.